JP2021519305A5 - - Google Patents
Info
- Publication number
- JP2021519305A5 JP2021519305A5 JP2020551882A JP2020551882A JP2021519305A5 JP 2021519305 A5 JP2021519305 A5 JP 2021519305A5 JP 2020551882 A JP2020551882 A JP 2020551882A JP 2020551882 A JP2020551882 A JP 2020551882A JP 2021519305 A5 JP2021519305 A5 JP 2021519305A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- antigen
- amino acid
- acid sequence
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862647911P | 2018-03-26 | 2018-03-26 | |
| US62/647,911 | 2018-03-26 | ||
| PCT/US2019/024052 WO2019191079A1 (en) | 2018-03-26 | 2019-03-26 | Methods and compositions for targeting liver and lymph node sinusoidal endothelial cell c-type lectin (lsectin) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021519305A JP2021519305A (ja) | 2021-08-10 |
| JP2021519305A5 true JP2021519305A5 (https=) | 2022-04-01 |
| JPWO2019191079A5 JPWO2019191079A5 (https=) | 2022-04-01 |
Family
ID=68060405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551882A Pending JP2021519305A (ja) | 2018-03-26 | 2019-03-26 | 肝臓およびリンパ節の類洞内皮細胞Ｃ型レクチン（ＬＳＥＣｔｉｎ）を標的とするための方法および組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20210171642A1 (https=) |
| EP (1) | EP3774890A4 (https=) |
| JP (1) | JP2021519305A (https=) |
| WO (1) | WO2019191079A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012021512A2 (en) | 2010-08-10 | 2012-02-16 | Ecole Polytechnique Federale De Lausanne | Erythrocyte-binding therapeutics |
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| KR102717969B1 (ko) | 2014-02-21 | 2024-10-15 | 에꼴 뽈리떼끄닉 뻬데랄 드 로잔느 (으뻬에프엘) | 글리코타겟팅 치료제 |
| US11253579B2 (en) | 2017-06-16 | 2022-02-22 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
| EA202092723A1 (ru) | 2018-05-09 | 2021-04-09 | Зе Юниверсити Оф Чикаго | Композиции и способы, касающиеся иммунной толерантности |
| CN113710229B (zh) | 2019-02-25 | 2026-01-06 | 芝加哥大学 | 用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物 |
| KR20250005069A (ko) * | 2022-02-18 | 2025-01-17 | 더 유니버서티 오브 시카고 | 성장호르몬 수용체 표적 폴리펩티드 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080171059A1 (en) * | 2006-08-07 | 2008-07-17 | Shanshan Wu Howland | Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens |
| TW200846363A (en) * | 2007-03-22 | 2008-12-01 | Urrma R & B | Novel human anti-R7V antibodies and uses thereof |
| AU2009227935B2 (en) * | 2008-03-28 | 2015-07-09 | Mdna Life Sciences Inc. | Aberrant mitochondrial DNA, associated fusion transcripts and hybridization probes therefor |
| WO2017044308A1 (en) * | 2015-09-10 | 2017-03-16 | Albert Einstein College Of Medicine, Inc. | Synthetic antibodies to bax and uses thereof |
-
2019
- 2019-03-26 WO PCT/US2019/024052 patent/WO2019191079A1/en not_active Ceased
- 2019-03-26 EP EP19774313.1A patent/EP3774890A4/en not_active Withdrawn
- 2019-03-26 JP JP2020551882A patent/JP2021519305A/ja active Pending
- 2019-03-26 US US15/733,657 patent/US20210171642A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021519305A5 (https=) | ||
| JP7840836B2 (ja) | 改善された血清アルブミン結合性免疫グロブリン可変ドメイン | |
| JP7453206B2 (ja) | 改良された血清アルブミン結合剤 | |
| JP2021191763A5 (https=) | ||
| JP2020522261A5 (https=) | ||
| JP2021503455A5 (https=) | ||
| JP2021510710A5 (https=) | ||
| JP2006020633A (ja) | 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法 | |
| JP2011509245A5 (https=) | ||
| JP2010536384A5 (https=) | ||
| RU2015136078A (ru) | Антитело против с5 и способ предупреждения и лечения обусловленных комплементом заболеваний | |
| TW201014602A (en) | Prostaglandin E2 binding proteins and uses thereof | |
| RU2765878C2 (ru) | Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний | |
| KR20130137584A (ko) | 수동 인플루엔자 면역에 유용한 항체 | |
| JP7743406B2 (ja) | 抗ｂｃｍａ ｃａｒ抗体、コンジュゲートおよび使用方法 | |
| JP2019507580A5 (https=) | ||
| JP2019504615A5 (https=) | ||
| JP2024001073A5 (https=) | ||
| JPWO2020059847A5 (https=) | ||
| JP2021511387A5 (https=) | ||
| JPWO2019191079A5 (https=) | ||
| JPWO2021032963A5 (https=) | ||
| JP2018531625A5 (https=) | ||
| JPWO2022111425A5 (https=) | ||
| JP2025130076A5 (https=) |